Department of Oral and Maxillofacial Surgery, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.
Peking University Shenzhen Hospital Clinical College, Anhui Medical University, Hefei, Anhui, China.
J Cell Mol Med. 2019 Apr;23(4):2645-2655. doi: 10.1111/jcmm.14160. Epub 2019 Jan 24.
Oral squamous cell carcinoma (OSCC) is an oral and maxillofacial malignancy that exhibits high incidence worldwide. In diverse human cancers, the long non-coding RNA (lncRNA) highly up-regulated in liver cancer (HULC) is aberrantly expressed, but how HULC affects OSCC development and progression has remained mostly unknown. We report that HULC was abnormally up-regulated in oral cancer tissues and OSCC cell lines, and that suppression of HULC expression in OSCC cells not only inhibited the proliferation, drug tolerance, migration and invasion of the cancer cells, but also increased their apoptosis rate. Notably, in a mouse xenograft model, HULC depletion reduced tumorigenicity and inhibited the epithelial-to-mesenchymal transition process. Collectively, our findings reveal a crucial role of the lncRNA HULC in regulating oral cancer carcinogenesis and tumour progression, and thus suggest that HULC could serve as a novel therapeutic target for OSCC.
口腔鳞状细胞癌(OSCC)是一种口腔和颌面恶性肿瘤,在世界范围内发病率较高。在多种人类癌症中,肝癌中高表达的长链非编码 RNA(lncRNA)HULC 表达异常,但 HULC 如何影响 OSCC 的发生和发展在很大程度上尚不清楚。我们报告 HULC 在口腔癌组织和 OSCC 细胞系中异常上调,抑制 OSCC 细胞中的 HULC 表达不仅抑制了癌细胞的增殖、耐药性、迁移和侵袭,还增加了它们的凋亡率。值得注意的是,在小鼠异种移植模型中,HULC 的耗竭降低了致瘤性并抑制了上皮间质转化过程。总之,我们的研究结果揭示了 lncRNA HULC 在调节口腔癌发生和肿瘤进展中的关键作用,因此提示 HULC 可作为 OSCC 的一种新的治疗靶点。